CGEN: Compugen Ltd. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 210.41
Enterprise Value ($M) 203.19
Book Value ($M) 60.49
Book Value / Share 0.68
Price / Book 3.48
NCAV ($M) 51.80
NCAV / Share 0.58
Price / NCAV 4.06

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.01
Return on Equity (ROE) 0.02

Liquidity (mrq)
Quick Ratio 4.14
Current Ratio 4.14

Balance Sheet (mrq) ($M)
Current Assets 114.83
Assets 123.52
Liabilities 63.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 69,981 299,789 23.34
2025-01-30 52,179 416,149 12.54
2025-01-29 45,461 289,326 15.71
2025-01-28 26,489 329,139 8.05
2025-01-27 77,878 661,957 11.76

(click for more detail)

Similar Companies
CDXC – ChromaDex Corporation CELU – Celularity Inc.
CELZ – Creative Medical Technology Holdings, Inc. CING – Cingulate Inc.
CKPT – Checkpoint Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io